QIPT vs. PSNL, VMD, LFMD, DCGO, TOI, SERA, CORBF, ATPC, AIRS, and EUDA
Should you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include Personalis (PSNL), Viemed Healthcare (VMD), LifeMD (LFMD), DocGo (DCGO), Oncology Institute (TOI), Sera Prognostics (SERA), Global Cord Blood (CORBF), Agape ATP (ATPC), AirSculpt Technologies (AIRS), and EUDA Health (EUDA). These companies are all part of the "healthcare" industry.
Quipt Home Medical vs.
Personalis (NASDAQ:PSNL) and Quipt Home Medical (NASDAQ:QIPT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, community ranking, valuation, institutional ownership and profitability.
Personalis currently has a consensus target price of $7.80, indicating a potential upside of 103.66%. Quipt Home Medical has a consensus target price of $6.25, indicating a potential upside of 192.06%. Given Quipt Home Medical's higher possible upside, analysts clearly believe Quipt Home Medical is more favorable than Personalis.
61.9% of Personalis shares are held by institutional investors. Comparatively, 42.8% of Quipt Home Medical shares are held by institutional investors. 3.8% of Personalis shares are held by company insiders. Comparatively, 13.4% of Quipt Home Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Quipt Home Medical has a net margin of -2.90% compared to Personalis' net margin of -104.52%. Quipt Home Medical's return on equity of -6.70% beat Personalis' return on equity.
Personalis has a beta of 1.89, indicating that its share price is 89% more volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500.
Quipt Home Medical has higher revenue and earnings than Personalis. Quipt Home Medical is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks.
In the previous week, Personalis had 4 more articles in the media than Quipt Home Medical. MarketBeat recorded 4 mentions for Personalis and 0 mentions for Quipt Home Medical. Personalis' average media sentiment score of 0.92 beat Quipt Home Medical's score of 0.00 indicating that Personalis is being referred to more favorably in the media.
Personalis received 94 more outperform votes than Quipt Home Medical when rated by MarketBeat users. However, 83.78% of users gave Quipt Home Medical an outperform vote while only 68.31% of users gave Personalis an outperform vote.
Summary
Quipt Home Medical beats Personalis on 10 of the 18 factors compared between the two stocks.
Get Quipt Home Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quipt Home Medical Competitors List
Related Companies and Tools
This page (NASDAQ:QIPT) was last updated on 4/25/2025 by MarketBeat.com Staff
Buy QIPT Stock Free QIPT Stock Alerts